Skip to main content
. Author manuscript; available in PMC: 2020 Oct 15.
Published in final edited form as: Clin Cancer Res. 2020 Jan 14;26(8):2011–2021. doi: 10.1158/1078-0432.CCR-19-2884

Figure 1:

Figure 1:

Schematic drawing of our bioinformatic analysis. RNA-Seq was performed on well-differentiated PNET samples from 43 patients. Gene expression in the primary tumors was compared to the metastases to derive a metastatic expression profile which was analyzed using IPA and CMap to produce a list of therapeutic agents. A subset of these drugs were then tested against BON-1 and QGP-1.